Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ERHSX vs. XLV: which is better?

Bottom line

ERHSX vs XLV: the short answer

ERHSX (Eaton Vance Worldwide Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

XLV is cheaper at 0.08% vs 1.43% — a difference of $135 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +6.2% for ERHSX (reporting dates differ).

Updated Nov 19, 2026

ERHSX vs XLV side by side

ERHSXXLV
TypeMutual fundETF
Fund familyMorgan StanleySPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.43%0.08%
Annual cost per $10k$143$8
10-yr cost on $10k (prospectus)$1,744$103
Max front load0%None
12b-1 fee0.5%0.02%
1-yr return+3.2%+14.5%
5-yr return (annualized)+6.2%+8.1%
10-yr return (annualized)+6.7%+9.8%
Best quarter—+14.5%
Worst quarter—−12.7%
Net assets (fund)$757.9M$40.6B
Number of holdings4265
Portfolio turnover3%2%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

14 of ERHSX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingERHSXXLV
Eli Lilly & Co12.47%16.51%
AbbVie Inc6.46%7.74%
Johnson & Johnson6.45%10.64%
UnitedHealth Group Inc5.49%6.57%
Merck & Co Inc5.08%5.52%
Bristol-Myers Squibb Co4.25%2.05%
Vertex Pharmaceuticals Inc3.38%2.19%
Gilead Sciences Inc3.34%2.73%
Thermo Fisher Scientific Inc2.79%3.24%
Intuitive Surgical Inc2.72%2.45%
Stryker Corp2.21%1.89%
Boston Scientific Corp2.18%1.10%
Medtronic PLC1.80%1.75%
Abbott Laboratories1.65%2.75%

Source: SEC Form N-PORT

ERHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between ERHSX and XLV?
ERHSX (Eaton Vance Worldwide Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.43% — a difference of $135 a year per $10,000 invested.
Which is cheaper, ERHSX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both ERHSX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.